Logo image of BYRN

BYRNA TECHNOLOGIES INC (BYRN) Stock Fundamental Analysis

NASDAQ:BYRN - US12448X2018 - Common Stock

20.2 USD
+0.99 (+5.15%)
Last: 8/22/2025, 8:00:02 PM
20.1 USD
-0.1 (-0.5%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, BYRN scores 6 out of 10 in our fundamental rating. BYRN was compared to 68 industry peers in the Aerospace & Defense industry. BYRN has an excellent financial health rating, but there are some minor concerns on its profitability. BYRN is valued quite expensively, but it does show have an excellent growth rating. These ratings would make BYRN suitable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

BYRN had positive earnings in the past year.
BYRN had a negative operating cash flow in the past year.
In the past 5 years BYRN reported 4 times negative net income.
In multiple years BYRN reported negative operating cash flow during the last 5 years.
BYRN Yearly Net Income VS EBIT VS OCF VS FCFBYRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of 19.09%, BYRN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
BYRN's Return On Equity of 24.59% is amongst the best of the industry. BYRN outperforms 92.65% of its industry peers.
BYRN's Return On Invested Capital of 12.65% is amongst the best of the industry. BYRN outperforms 92.65% of its industry peers.
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROIC 12.65%
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
BYRN Yearly ROA, ROE, ROICBYRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

BYRN has a better Profit Margin (14.28%) than 91.18% of its industry peers.
BYRN has a better Operating Margin (9.60%) than 64.71% of its industry peers.
BYRN's Gross Margin of 61.88% is amongst the best of the industry. BYRN outperforms 97.06% of its industry peers.
In the last couple of years the Gross Margin of BYRN has grown nicely.
Industry RankSector Rank
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
BYRN Yearly Profit, Operating, Gross MarginsBYRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

8

2. Health

2.1 Basic Checks

BYRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BYRN has been increased compared to 1 year ago.
BYRN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BYRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BYRN Yearly Shares OutstandingBYRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
BYRN Yearly Total Debt VS Total AssetsBYRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

BYRN has an Altman-Z score of 16.54. This indicates that BYRN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 16.54, BYRN belongs to the best of the industry, outperforming 97.06% of the companies in the same industry.
BYRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.54
ROIC/WACC1.27
WACC9.93%
BYRN Yearly LT Debt VS Equity VS FCFBYRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 3.63 indicates that BYRN has no problem at all paying its short term obligations.
BYRN's Current ratio of 3.63 is amongst the best of the industry. BYRN outperforms 80.88% of its industry peers.
A Quick Ratio of 1.53 indicates that BYRN should not have too much problems paying its short term obligations.
BYRN has a Quick ratio (1.53) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.63
Quick Ratio 1.53
BYRN Yearly Current Assets VS Current LiabilitesBYRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1450.00% over the past year.
BYRN shows a strong growth in Revenue. In the last year, the Revenue has grown by 73.55%.
Measured over the past years, BYRN shows a very strong growth in Revenue. The Revenue has been growing by 147.68% on average per year.
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%

3.2 Future

BYRN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.26% yearly.
Based on estimates for the next years, BYRN will show a quite strong growth in Revenue. The Revenue will grow by 18.79% on average per year.
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue Next Year35.48%
Revenue Next 2Y28.2%
Revenue Next 3Y28.82%
Revenue Next 5Y18.79%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BYRN Yearly Revenue VS EstimatesBYRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
BYRN Yearly EPS VS EstimatesBYRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.58, BYRN can be considered very expensive at the moment.
73.53% of the companies in the same industry are more expensive than BYRN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.24, BYRN is valued at the same level.
A Price/Forward Earnings ratio of 26.23 indicates a quite expensive valuation of BYRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BYRN indicates a somewhat cheap valuation: BYRN is cheaper than 63.24% of the companies listed in the same industry.
BYRN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 32.58
Fwd PE 26.23
BYRN Price Earnings VS Forward Price EarningsBYRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

BYRN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.49
BYRN Per share dataBYRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

BYRN has a very decent profitability rating, which may justify a higher PE ratio.
BYRN's earnings are expected to grow with 12.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.45%
EPS Next 3Y12.26%

More info and screens

0

5. Dividend

5.1 Amount

BYRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BYRNA TECHNOLOGIES INC

NASDAQ:BYRN (8/22/2025, 8:00:02 PM)

After market: 20.1 -0.1 (-0.5%)

20.2

+0.99 (+5.15%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-07 2025-10-07/bmo
Inst Owners59.52%
Inst Owner Change9.21%
Ins Owners19.32%
Ins Owner Change-0.24%
Market Cap458.54M
Analysts83.64
Price Target39.27 (94.41%)
Short Float %20.26%
Short Ratio5.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.56%
Min EPS beat(2)21.04%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)104.71%
Min EPS beat(4)21.04%
Max EPS beat(4)254.68%
EPS beat(8)6
Avg EPS beat(8)-36.83%
EPS beat(12)8
Avg EPS beat(12)-9.3%
EPS beat(16)9
Avg EPS beat(16)-27.67%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)1.52%
Revenue beat(4)1
Avg Revenue beat(4)-0.75%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)1.52%
Revenue beat(8)4
Avg Revenue beat(8)4.49%
Revenue beat(12)4
Avg Revenue beat(12)-1.24%
Revenue beat(16)5
Avg Revenue beat(16)-1.7%
PT rev (1m)2.33%
PT rev (3m)8.07%
EPS NQ rev (1m)-29.28%
EPS NQ rev (3m)-30.81%
EPS NY rev (1m)0%
EPS NY rev (3m)1.45%
Revenue NQ rev (1m)-1.12%
Revenue NQ rev (3m)0.18%
Revenue NY rev (1m)0.37%
Revenue NY rev (3m)2.9%
Valuation
Industry RankSector Rank
PE 32.58
Fwd PE 26.23
P/S 4.43
P/FCF N/A
P/OCF N/A
P/B 7.63
P/tB 8.39
EV/EBITDA 35.49
EPS(TTM)0.62
EY3.07%
EPS(NY)0.77
Fwd EY3.81%
FCF(TTM)-0.38
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS4.56
BVpS2.65
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.09%
ROE 24.59%
ROCE 16.01%
ROIC 12.65%
ROICexc 16%
ROICexgc 18%
OM 9.6%
PM (TTM) 14.28%
GM 61.88%
FCFM N/A
ROA(3y)-3.9%
ROA(5y)-15.32%
ROE(3y)-4.33%
ROE(5y)-33.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y30.43%
F-Score6
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 289.39%
Cap/Sales 5.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.63
Quick Ratio 1.53
Altman-Z 16.54
F-Score6
WACC9.93%
ROIC/WACC1.27
Cap/Depr(3y)202.29%
Cap/Depr(5y)309.93%
Cap/Sales(3y)3.87%
Cap/Sales(5y)4.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-42.42%
EPS Next 2Y11.45%
EPS Next 3Y12.26%
EPS Next 5YN/A
Revenue 1Y (TTM)73.55%
Revenue growth 3Y26.7%
Revenue growth 5Y147.68%
Sales Q2Q%40.63%
Revenue Next Year35.48%
Revenue Next 2Y28.2%
Revenue Next 3Y28.82%
Revenue Next 5Y18.79%
EBIT growth 1Y407.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year223.74%
EBIT Next 3Y91.87%
EBIT Next 5Y53.44%
FCF growth 1Y-58.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.81%
OCF growth 3YN/A
OCF growth 5YN/A